Solicitation for the Nomination of Candidates To Serve as Voting Members and Representatives of the National Vaccine Advisory Committee, 70776-70777 [E6-20636]

Download as PDF 70776 Federal Register / Vol. 71, No. 234 / Wednesday, December 6, 2006 / Notices Use: The purpose of the data collection and evaluation is to determine the efficacy of the National Abstinence Media Campaign and its messages upon parents, specifically to encourage and help parents talk to their pre-teens and teens about waiting to have sex. The following outcomes will be examined: perceived risks from teen sexual activity, perceived susceptibility, attitude towards teen sexual activity, self-efficacy to talk to their child, outcome efficacy, perceived value of delayed sexual activity, and parentchild communication about sex. Frequency: Reporting on Occasion. Affected Public: Individuals or Households. Annual Number of Respondents: 947.5. Total Annual Responses: 3,493.5. Average Burden Per Response: 30 mins. Total Annual Hours: 1,746.75. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to Sherette.funncoleman@hhs.gov, or call the Reports Clearance Office on (202) 690–6162. Written comments and recommendations for the proposed information collections must be received within 30 days of this notice directly to the Desk Officer at the address below: OMB Desk Officer: John Kraemer, OMB Human Resources and Housing Branch, Attention: (OMB #0990–New), New Executive Office Building, Room 10235, Washington, DC 20503. Dated: November 28, 2006. Alice Bettencourt, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. E6–20583 Filed 12–5–06; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES PWALKER on PRODPC60 with NOTICES [Document Identifier: OS–0990–0000; 30day notice] Office of the Secretary; Agency Information Collection Activities: Proposed Collection; Comment Request Agency: Office of the Secretary, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department VerDate Aug<31>2005 16:03 Dec 05, 2006 Jkt 211001 of Health and Human Services, is publishing the following summary of a proposed collection for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Type of Information Collection Request: New Collection. Title of Information Collection: The Heart Truth Professional Materials Program Evaluation. Form/OMB No.: OS–0990–0000. Use: The Heart Truth Campaign was launched by the National Heart, Lung, and Blood Institute (NHLBI) in September 2002 to increase women’s awareness of heart disease. The Heart Truth joins together leaders in women’s health—along with corporate and media partners—to create a national movement aimed at delivering an urgent wake-up call to women about heart disease. As part of The Heart Truth campaign, Office on Women’s Health funded programs to develop and disseminate educational materials for health care professionals. This information collection ascertains whether health care professionals exposed to the program materials have incorporated what they learned into their professional practice. Frequency: One time. Affected Public: Individuals or Households. Annual Number of Respondents: 400. Total Annual Responses: 400. Average Burden Per Response: 0.1 hours. Total Annual Hours: 40 hours. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to Sherette.funncoleman@hhs.gov, or call the Reports Clearance Office on (202) 690–6162. Written comments and recommendations for the proposed information collections must be received within 30 days of this notice directly to the Desk Officer at the address below: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 OMB Desk Officer: John Kraemer, OMB Human Resources and Housing Branch, Attention: (OMB #0990–0000), New Executive Office Building, Room 10235, Washington, DC 20503. Dated: November 28, 2006. Alice Bettencourt, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. E6–20585 Filed 12–5–06; 8:45 am] BILLING CODE 4150–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation for the Nomination of Candidates To Serve as Voting Members and Representatives of the National Vaccine Advisory Committee Office of Public Health and Science, Office of the Secretary, HHS. ACTION: Notice. AGENCY: Authority: 42 U.S.C. 300aa–5, Section 2105 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The National Vaccine Program Office (NVPO), a program office within the Office of Public Health and Science, DHHS, is soliciting nominations of qualified candidates to be considered for appointment as members and representatives to the National Vaccine Advisory Committee (NVAC). The activities of this Committee are governed by the Federal Advisory Committee Act (FACA). Consistent with the National Vaccine Plan, the Committee advises and makes recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the Committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The Committee also advises the Assistant Secretary for Health in the implementation of Sections 2102 and 2103 of the PHS Act; and identifies annually the most important areas of government and non-government cooperation that should be considered in implementing Sections 2102 and 2103 of the PHS Act. DATES: Nominations for membership on the Committee must be received no later E:\FR\FM\06DEN1.SGM 06DEN1 PWALKER on PRODPC60 with NOTICES Federal Register / Vol. 71, No. 234 / Wednesday, December 6, 2006 / Notices than 5 p.m. EST on January 19, 2007, at the address below. ADDRESSES: Bruce G. Gellin, M.D., M.P.H., Executive Secretary, National Vaccine Advisory Committee, Office of Public Health and Science, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443– H, Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Washington, DC 20201; (202) 690–5566; nvac@osophs.dhhs.gov. A copy of the Committee charter and list of the current membership can be obtained by contacting Ms. English or by accessing the NVAC Web site at: https://www.hhs.gov/nvpo/nvac. SUPPLEMENTARY INFORMATION: Committee Function: Qualifications and Information Required: As part of an ongoing effort to enhance deliberations and discussions with the public on vaccine and immunization policy, nominations are being sought for interested individuals to serve on the Committee. Individuals selected for appointment to the Committee will serve as voting members. Voting members shall be selected from individuals who are engaged in vaccine research or the manufacture of vaccines, or who are physicians, members of parent organizations concerned with immunizations, representatives of State or local health agencies, or public health organizations. Individuals selected for appointment to the Committee can be invited to serve terms with periods of up to four years. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee; (2) the nominator’s name, address, and daytime telephone number, and the home and/ or work address, telephone number, and e-mail address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Applications cannot be submitted by facsimile. The names of Federal employees should not be submitted for consideration of appointment to this Committee. VerDate Aug<31>2005 16:03 Dec 05, 2006 Jkt 211001 The Department makes every effort to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made to ensure that a broad representation of geographic areas, gender, ethnic and minority groups, and the disabled are given consideration for membership on HHS Federal advisory committees. Appointment to this committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Dated: November 30, 2006. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E6–20636 Filed 12–5–06; 8:45 am] 70777 panel discussion on the American Health Information Management Association’s State Steering Committee Recommendations; and an update on the National Health Information Network (NHIN). The instructions to participate remotely (Web cast and/or telephone) can be found at https:// www.hhs.gov/healthit/m20061212.html. If you have any questions concerning the remote instructions or meeting format, please call (866) 505–3500. Dated: November 30, 2006. Judith Sparrow, Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 06–9549 Filed 12–5–06; 8:45 am] BILLING CODE 4150–24–M BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; American Health Information Community Meeting Amendment of meeting announcement, dated November 28, 2006. ACTION: SUMMARY: This notice amends the announcement of the tenth meeting of the American Health Information Community in accordance with the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App.) The American Health Information Community will advise the Secretary and recommend specific actions to achieve a common interoperability framework for health information technology (IT). DATES: December 12, 2006, from 8:30 to 11:30 a.m. Meeting Format: This meeting was originally scheduled to be held in the Hubert H. Humphrey Building (200 Independence Avenue, SW., Washington, DC 20201), Conference Room 800. However, the meeting format has been changed to provide remote participation only (Web cast and/or telephone) for the Community members, HHS staff, invited presenters, and general public. A time period will be allotted before the conclusion of the meeting for the general public to deliver brief (3 minutes or less) oral public comment. The agenda includes an update on the Personalized Healthcare Workgroup; a SUPPLEMENTARY INFORMATION: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, Department of Health and Human Services. AGENCY: ACTION: Notice. SUMMARY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) allow the proposed information collection project: ‘‘Pilot Study of Proposed Medical Office Surveys on Patient Safety.’’ In accordance with the Paperwork Reduction Act of 1995, Public Law 104– 13 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection. Comments on this notice must be received by February 5, 2007. DATES: Written comments should be submitted to: Doris Lefkowitz, Reports Clearance Officer, AHRQ, 540 Gaither Road, Room 5036, Rockville, MD 20850. Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from AHRQ’s Reports Clearance Officer. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ, Reports Clearance Officer, (301) 427–1477. SUPPLEMENTARY INFORMATION: E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 71, Number 234 (Wednesday, December 6, 2006)]
[Notices]
[Pages 70776-70777]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20636]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation for the Nomination of Candidates To Serve as Voting 
Members and Representatives of the National Vaccine Advisory Committee

AGENCY: Office of Public Health and Science, Office of the Secretary, 
HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of Public Health and Science, DHHS, is soliciting 
nominations of qualified candidates to be considered for appointment as 
members and representatives to the National Vaccine Advisory Committee 
(NVAC). The activities of this Committee are governed by the Federal 
Advisory Committee Act (FACA).
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on 
matters related to the Program's responsibilities.
    Specifically, the Committee studies and recommends ways to 
encourage the availability of an adequate supply of safe and effective 
vaccination products in the United States; recommends research 
priorities and other measures to enhance the safety and efficacy of 
vaccines. The Committee also advises the Assistant Secretary for Health 
in the implementation of Sections 2102 and 2103 of the PHS Act; and 
identifies annually the most important areas of government and non-
government cooperation that should be considered in implementing 
Sections 2102 and 2103 of the PHS Act.

DATES: Nominations for membership on the Committee must be received no 
later

[[Page 70777]]

than 5 p.m. EST on January 19, 2007, at the address below.

ADDRESSES: Bruce G. Gellin, M.D., M.P.H., Executive Secretary, National 
Vaccine Advisory Committee, Office of Public Health and Science, 
Department of Health and Human Services, 200 Independence Avenue, SW., 
Room 443-H, Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, 200 Independence Avenue, SW., Room 443-H, Washington, DC 
20201; (202) 690-5566; nvac@osophs.dhhs.gov.
    A copy of the Committee charter and list of the current membership 
can be obtained by contacting Ms. English or by accessing the NVAC Web 
site at: https://www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION: Committee Function: Qualifications and 
Information Required: As part of an ongoing effort to enhance 
deliberations and discussions with the public on vaccine and 
immunization policy, nominations are being sought for interested 
individuals to serve on the Committee. Individuals selected for 
appointment to the Committee will serve as voting members. Voting 
members shall be selected from individuals who are engaged in vaccine 
research or the manufacture of vaccines, or who are physicians, members 
of parent organizations concerned with immunizations, representatives 
of State or local health agencies, or public health organizations. 
Individuals selected for appointment to the Committee can be invited to 
serve terms with periods of up to four years.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee; (2) the nominator's name, 
address, and daytime telephone number, and the home and/or work 
address, telephone number, and e-mail address of the individual being 
nominated; and (3) a current copy of the nominee's curriculum vitae. 
Applications cannot be submitted by facsimile. The names of Federal 
employees should not be submitted for consideration of appointment to 
this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
to ensure that a broad representation of geographic areas, gender, 
ethnic and minority groups, and the disabled are given consideration 
for membership on HHS Federal advisory committees. Appointment to this 
committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.

    Dated: November 30, 2006.
Bruce Gellin,
Director, National Vaccine Program Office.
 [FR Doc. E6-20636 Filed 12-5-06; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.